CUSTOMER: AN INNOVATIVE LEADING BIOPHARMACEUTICAL COMPANY
This BIOVIA customer is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. The customer’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases such as hepatitis C, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. In the past 25 years, the organizations has grown to become one of the world’s largest biopharmaceutical companies with nearly 10,000 employees across six continents.
CHALLENGE: LACK OF INTEGRATION BETWEEN LAB SYSTEMS LEADING TO COMPLIANCE RISKS
Like most large pharmaceutical companies, this customer had previously transitioned from paper-based experimental documentation towards increasingly electronic-based systems. The first step was the implementation of a traditional Laboratory Information Management System (LIMS), where experimental data from instruments such as pH meters, balances and chromatography systems was captured in paper notebooks and transcribed manually into the LIMS. Paper notebooks still maintained records of all testing, and paper-based log forms tracked the associated chemical solutions and reagents utilized. Raw materials and other materials prepared in the QC labs for quality testing were managed manually.
Continue reading to learn how through the integration of their lab informatics systems the customer has observed improvements in both compliance and workflow efficiency.